Go back to News
NEWS
Santiago Garrido among the most outstanding recruitments of the year | Expansión
Expansión gathers the most relevant signings of 2022 in law firms. This year, Santiago Garrido, Public and Regulatory Law partner at Gómez-Acebo & Pombo, is included among the most important additions to Spanish law firms.
Read full article.
Read full article.
Lawyer mentioned
Santiago Garrido de las Heras – Partner
Areas and sectors
Press contact
Sandra Cuesta
Director of Business Development, Marketing and Communications
Sandra Cuesta
Director of Business Development, Marketing and Communications
More information about
Gómez-Acebo & Pombo
PUBLICATION
29 Oct, 2025
Recent developments in the carbon border adjustment mechanism: simplifications and obligations as of 2026
Regulation (EU) 2025/2083 simplifies the carbon border adjustment mechanism in order to reduce burdens as of 1 January 2026. This paper explains the obligations imposed by this mechanism on the importers it applies to and the simplification measures introduced, including the de minimis exemption based on mass for small importers, excluding electricity and hydrogen.
PUBLICATION
28 Oct, 2025
Borderline products and the precedence of medicinal product legislation
The application of the rule of precedence requires, firstly, that a given product falls within the legal definition of a medicinal product, whether it is a medicinal product by function or by presentation, and secondly, that there are doubts as to whether it also falls within the legal concept of other types of products (food supplements, cosmetics, etc.).
PUBLICATION
25 Sep, 2025
Prohibition of arbitration in the single energy market
The Agreement on the interpretation and application of the Energy Charter Treaty gives the force and effect of law to the case law of the Court of Justice of the European Union, according to which Article 26 of the Energy Charter Treaty does not and could not apply as a legal basis for intra-EU arbitration proceedings as a mechanism for the settlement of disputes between a contracting State and an investor of another contracting State.
PUBLICATION
25 Sep, 2025
Pharma & Healthcare No. 45
The newsletter covers the main developments in Pharma & Healthcare legislation and case law.
PUBLICATION
15 Sep, 2025
The Unified Patent Court takes jurisdiction to hear a claim concerning the infringement of the UK national part of a European patent, even when the validity of the patent is being disputed
In a decision dated 18 July 2025, the Mannheim Division of the Court of First Instance of the Unified Patent Court took jurisdiction to hear a claim filed against three companies domiciled in Germany for infringement of a classic European patent with effect in Germany and the United Kingdom. The court's jurisdiction to hear the infringement of the UK national part of European patents is not affected by the fact that the validity of the patent is disputed by the defendants. However, this conclusion does not apply to Spanish national parts of European patents.
PUBLICATION
30 Jul, 2025
Absolute prohibitions on pharmacy advertising are contrary to EU law
In its judgment of 19 June 2025 (European Commission v Republic of Poland, C‑200/24, ECLI:EU:C:2025:459), the Court of Justice has held that the introduction by national legislation of a total prohibition on advertising for pharmacies infringes European Union law.
PUBLICATION
02 Jul, 2025
Pharma & Healthcare No. 44
The newsletter covers the main developments in Pharma & Healthcare legislation and case law.
PUBLICATION
30 Jun, 2025
Main changes introduced by RDL 7/2025 to the milestone system applied in the processing of renewable energy generation projects
Royal Decree-law 7/2025 introduces new regulations which modify and extend the milestone system applied in the processing of renewable energy generation projects
PUBLICATION
30 Jun, 2025
Main changes introduced by RDL 7/2025 regarding electricity storage projects
Royal Decree-law 7/2025 introduces regulatory changes to the processing and deployment of electricity storage projects